<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35957578</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1945-8932</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>American journal of rhinology &amp; allergy</Title><ISOAbbreviation>Am J Rhinol Allergy</ISOAbbreviation></Journal><ArticleTitle>Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>101</EndPage><MedlinePgn>95-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/19458924221120117</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nearly 40% of patients who experience smell loss during SARS-CoV-2 infection may develop qualitative olfactory dysfunction, most commonly parosmia. Our evidence-based review summarizes the evolving literature and offers recommendations for the clinician on the management of patients experiencing parosmia associated with COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic search using independent queries in PubMed, Embase, Ovid, and Cochrane databases, then categorized articles according to themes that emerged regarding epidemiology, effect on quality of life, disease progression, prognosis, pathophysiology, diagnosis, and treatment of parosmia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 123 unique references meeting eligibility and performed title and abstract review with 2 independent reviewers, with 74 articles undergoing full-text review. An inductive approach to thematic development provided 7 central themes regarding qualitative olfactory dysfunction following COVID-19.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While other respiratory viruses are known to cause qualitative olfactory disturbances, the incidence of parosmia following COVID-19 is notable, and correlates negatively with age. The presence of parosmia predicts persistent quantitative olfactory dysfunction. Onset can occur months after infection, and symptoms may persist for well over 7 months. Affected patients report increased anxiety and decreased quality of life. Structured olfactory training with essential oils is the preferred treatment, where parosmia predicts recovery of aspects of quantitative smell loss when undergoing training. There is limited evidence that nasal corticosteroids may accelerate recovery of olfactory function. Patients should be prepared for the possibility that symptoms may persist for years, and providers should guide them to resources for coping with their psychosocial burden.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gary</LastName><ForeName>Joseph B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0003-4650-555X</Identifier><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, 5798Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallagher</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, 5798Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Paule V</ForeName><Initials>PV</Initials><Identifier Source="ORCID">0000-0002-1198-9622</Identifier><AffiliationInfo><Affiliation>National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Nursing Research, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>10630Monell Chemical Senses Center, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudis</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-1938-9349</Identifier><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, 5798Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, 21611Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overdevest</LastName><ForeName>Jonathan B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-1152-2512</Identifier><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, 5798Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, 21611Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 DC019678</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 AG044303</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Rhinol Allergy</MedlineTA><NlmUniqueID>101490775</NlmUniqueID><ISSNLinking>1945-8932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">hyposmia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">olfactory training</Keyword><Keyword MajorTopicYN="N">parosmia</Keyword><Keyword MajorTopicYN="N">phantosmia</Keyword><Keyword MajorTopicYN="N">post viral olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">qualitative olfactory dysfunction</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>2</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35957578</ArticleId><ArticleId IdType="pmc">PMC9379596</ArticleId><ArticleId IdType="doi">10.1177/19458924221120117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis. Clin Otolaryngol. 2020;45(6):914&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436734</ArticleId><ArticleId IdType="pubmed">32741085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, et al.Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277(8):2251&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, et al.Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Menegaldo A, Fabbris Cet al.Six-month psychophysical evaluation of olfactory dysfunction in patients with COVID-19. Chem Senses. Published online2021;46. doi:10.1093/chemse/bjab006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab006</ArticleId><ArticleId IdType="pmc">PMC7929204</ArticleId><ArticleId IdType="pubmed">33575808</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, et al.. Self-reported smell and taste recovery in COVID-19 patients: a one-year prospective study. medRxiv. Published online2021. doi:10.1101/2021.03.18.21253862</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.18.21253862</ArticleId><ArticleId IdType="pmc">PMC8103884</ArticleId><ArticleId IdType="pubmed">33963433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Vaira LA, et al.Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinol J. 2021;59(1):26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al.Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasnelli J, Hummel T. Olfactory dysfunction and daily life. Eur Arch Oto-Rhino-Laryngol. 2005;262(3):231&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">15133691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehling E, Nordin S, Espeseth T, Reinvang I, Lundervold AJ. Unawareness of olfactory dysfunction and its association with cognitive functioning in middle aged and old adults. Arch Clin Neuropsychol. 2011;26(3):260&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">21474482</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold D. Distortion of olfactory perception: diagnosis and treatment. Chem Senses. 2002;27(7):611&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">12200340</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis BN, Frasnelli J, Hummel T. Euosmia: a rare form of parosmia. Acta Otolaryngol. 2006;126(1):101&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">16308262</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Polesel J, Spinato G, et al.Predominance of an altered sense of smell or taste among long-lasting symptoms in patients with mildly symptomatic COVID-19. Rhinology. 2020;58(5):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32683438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SC, Holbrook EH, Leopold DA, Hummel T. Distorted olfactory perception: a systematic review. Acta Otolaryngol. 2012;132(Suppl. 1):S27&#x2013;S31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22582778</ArticleId></ArticleIdList></Reference><Reference><Citation>Reden J, Maroldt H, Fritz A, Zahnert T, Hummel T. A study on the prognostic significance of qualitative olfactory dysfunction. Eur Arch Oto-Rhino-Laryngol. 2006;264(2):139&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">17006637</ArticleId></ArticleIdList></Reference><Reference><Citation>Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol - Head Neck Surg. 2014;140(10):951&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">25170573</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson DLB, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: anosmia, parosmia and the impact of long COVID-19. PLoS One. 2021;16(9):e0256998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462678</ArticleId><ArticleId IdType="pubmed">34559820</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott CM, Boak D. The impact of olfactory disorders in the United Kingdom. Chem Senses. 2014;39(8):711&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">25201900</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733708</ArticleId><ArticleId IdType="pubmed">23875929</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaaban N, H&#xf8;ier ATZB, Andersen BV. A detailed characterisation of appetite, sensory perceptional, and eating-behavioural effects of COVID-19: self-reports from the acute and post-acute phase of disease. Foods. 2021;10(4):892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072610</ArticleId><ArticleId IdType="pubmed">33921603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattes RD, Cowart BJ, Shiavo MA, et al.Dietary evaluation of patients with smell and/or taste disorders. Am J Clin Nutr. 1990;51(2):233&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">2305710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid RA, Alaqeedy AA, Al-Ani RM. Parosmia due to COVID-19 disease: a 268 case series. Indian J Otolaryngol Head Neck Surg. Published online2021. doi:10.1007/s12070-021-02630-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02630-9</ArticleId><ArticleId IdType="pmc">PMC8141364</ArticleId><ArticleId IdType="pubmed">34055592</ArticleId></ArticleIdList></Reference><Reference><Citation>Deems DA, Doty RL, Settle RG, et al.Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Neck Surg. 1991;117(5):519&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">2021470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayin &#x130;, Ya&#x15f;ar KK, Yazici ZM. Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting tool-based comparative study. Otolaryngol - Head Neck Surg (United States). 2020;163(3):473&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7284454</ArticleId><ArticleId IdType="pubmed">32513096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum ME, Ramirez VA, Lipson SJ, et al.Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: a systematic review and meta-analysis. Chem Senses. 2020;45(9):865&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543258</ArticleId><ArticleId IdType="pubmed">33245136</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267531</ArticleId><ArticleId IdType="pubmed">32342636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathrin P, Veldhuizen MG, Niv MY, et al.. More than smell &#x2013; COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020;45(7):609&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337664</ArticleId><ArticleId IdType="pubmed">32564071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfils P, Avan P, Faulcon P, Malinvaud D. Distorted odorant perception: analysis of a series of 56 patients with parosmia. Arch Otolaryngol - Head Neck Surg. 2005;131(2):107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">15723940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohla K, Veldhuizen MG, Green T, et al.Increasing
incidence of parosmia and phantosmia in patients recovering from COVID-19
smell loss. medRxiv. Published
online2021:2021.08.28.21262763.
http://medrxiv.org/content/early/2021/08/31/2021.08.28.21262763.abstract.</Citation></Reference><Reference><Citation>Ferdenzi C, Bousquet C, Aguera PE, et al.Recovery from COVID-19-related olfactory disorders and quality of life: insights from an observational online study. Chem Senses. 2021;46. doi:10.1093/chemse/bjab028</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab028</ArticleId><ArticleId IdType="pubmed">34097726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner DK, Garvey KL, Arrighi-Allisan AE, et al.Clinical features of parosmia associated with COVID-19 infection. Laryngoscope. 2022;132(3):633&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015517</ArticleId><ArticleId IdType="pubmed">34870334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi&#xe8;re N, Mei J, L&#xe9;vesque-Boissonneault C, et al.. Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: a study of over 700 healthcare workers. Chem Senses. Published online August 23, 2021;46. doi:10.1093/chemse/bjab038</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab038</ArticleId><ArticleId IdType="pmc">PMC8499810</ArticleId><ArticleId IdType="pubmed">34423831</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaronidis J, Firman C, Magee CG, et al.Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people. BMC Infect Dis. 2021;21(1):221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905973</ArticleId><ArticleId IdType="pubmed">33632171</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzana A, Larsson M, M&#xfc;nch M, H&#xe4;hner A, Hummel T. Postinfectious olfactory loss: a retrospective study on 791 patients. Laryngoscope. 2018;128(1):10&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">28556265</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Sabha M, Damm M, et al.. Parosmia is associated with relevant olfactory recovery after olfactory training. Laryngoscope. 2021;131(3):618&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">33210732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombaux P, Weitz H, Mouraux A, et al.Olfactory function assessed with orthonasal and retronasal testing, olfactory bulb volume, and chemosensory event-related potentials. Arch Otolaryngol Head Neck Surg. 2006;132(12):1346&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">17178947</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, et al.Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31):1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M, Kodra A, Hoagland DA, et al.. Disruption of nuclear architecture as a cause of COVID-19 induced anosmia. bioRxiv Prepr Serv Biol. Published online2021. doi:10.1101/2021.02.09.430314</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.09.430314</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker JK, Kelly CE, Gane SB. Insights into the molecular triggers of parosmia based on gas chromatography olfactometry. Commun Med. 2022;2(1):47&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130211</ArticleId><ArticleId IdType="pubmed">35647609</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga H, Okuda K, Taki J, et al.Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection. Int Forum Allergy Rhinol. 2019;9(11):1252&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6899886</ArticleId><ArticleId IdType="pubmed">31356735</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag J, Ludwig G, Andreini I, R&#xf6;ssler P, Breer H. Olfactory receptors in aquatic and terrestrial vertebrates. J Comp Physiol A Sensory, Neural, Behav Physiol. 1998;183(5):635&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">9839455</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyan M, Ozturan IU, Altas M. Delayed parosmia following SARS-CoV-2 infection: a rare late complication of COVID-19. SN Compr Clin Med. 2021;3(5):1200&#x2013;1202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998087</ArticleId><ArticleId IdType="pubmed">33817555</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama S, Ueha R, Kondo K. Loss of smell and taste in patients with suspected COVID-19: what we can learn from patients&#x2019; reports on social media. J Med Internet Res. 2021;23(4):e26459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064705</ArticleId><ArticleId IdType="pubmed">33788699</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi-Koma A, Haseli S, Bakhshayeshkaram M, Raad N, Karimi-Galougahi M. Multimodality imaging with PET/CT and MRI reveals hypometabolism in tertiary olfactory cortex in parosmia of COVID-19. Acad Radiol. 2021;28(5):749&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857079</ArticleId><ArticleId IdType="pubmed">33582030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombaux P, Duprez T, Hummel T. Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology. 2009;47(1):3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19382487</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannilli E, Leopold DA, Hornung DE, Hummel T. Advances in understanding parosmia: an fMRI study. ORL. 2019;81(4):185&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">31238309</ArticleId></ArticleIdList></Reference><Reference><Citation>Gent JF, Goodspeed RB, Zagraniski RT, Catalanotto FA. Taste and smell problems: validation of questions for the clinical history. Yale J Biol Med. 1987;60(1):27&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2590232</ArticleId><ArticleId IdType="pubmed">3564547</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Lechien JR, Khalife M, et al.. Psychophysical evaluation of the olfactory function: European multicenter study on 774 COVID-19 patients. Pathogens. 2021;10(1):62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7827350</ArticleId><ArticleId IdType="pubmed">33445604</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis BN, Frasnelli J, Croy I, Hummel T. Evaluating the clinical usefulness of structured questions in parosmia assessment. Laryngoscope. 2010;120(8):1707&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pubmed">20641087</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Welge-L&#xfc;ssen A, Besser G, Mueller CA, Renner B. Assessment of odor hedonic perception: the Sniffin&#x2019; sticks parosmia test (SSParoT). Sci Rep. 2020;10(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581750</ArticleId><ArticleId IdType="pubmed">33093474</ArticleId></ArticleIdList></Reference><Reference><Citation>Addison AB, Wong B, Ahmed T, et al.Clinical olfactory working group consensus statement on the treatment of post infectious olfactory dysfunction. J Allergy Clin Immunol. 2021;147(5):1704&#x2013;1719.</Citation><ArticleIdList><ArticleId IdType="pubmed">33453291</ArticleId></ArticleIdList></Reference><Reference><Citation>AbScent. The
smell training technique. Published 2022.
Accessed June 28, 2022. https://abscent.org/learn-us/smell-training/how-smell-train</Citation></Reference><Reference><Citation>Altundag A, Cayonu M, Kayabasoglu G, et al.Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope. 2015;125(8):1763&#x2013;1766.</Citation><ArticleIdList><ArticleId IdType="pubmed">26031472</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A, Y&#x131;lmaz E, Kesimli MC. Modified olfactory training is an effective treatment method for COVID-19 induced parosmia. Laryngoscope. 2022;132(7):1433&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088368</ArticleId><ArticleId IdType="pubmed">35257391</ArticleId></ArticleIdList></Reference><Reference><Citation>Saussez S, Vaira LA, Chiesa-Estomba CM, et al.Short-term efficacy and safety of oral and nasal corticosteroids in COVID-19 patients with olfactory dysfunction: a European multicenter study. Pathogens. 2021;10(6):698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228154</ArticleId><ArticleId IdType="pubmed">34199734</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan CH, Overdevest JB, Patel ZM. Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations. Int Forum Allergy Rhinol. 2019;9(2):165&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">30472771</ArticleId></ArticleIdList></Reference><Reference><Citation>Overdevest JB. Unpublished data.</Citation></Reference><Reference><Citation>Whitcroft KL, Gunder N, Cuevas M, et al.Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients. Eur Arch Oto-Rhino-Laryngol. 2021;278(8):2891&#x2013;2897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266781</ArticleId><ArticleId IdType="pubmed">33471169</ArticleId></ArticleIdList></Reference><Reference><Citation>Welge-L&#xfc;ssen A. Re-establishment of olfactory and
taste functions. GMS Curr Top Otorhinolaryngol Head
Neck Surg.
2005;4:Doc06. http://www.ncbi.nlm.nih.gov/pubmed/22073054%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3201003</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3201003</ArticleId><ArticleId IdType="pubmed">22073054</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori E, Merkonidis C, Cuevas M, Gudziol V, Matsuwaki Y, Hummel T. The administration of nasal drops in the &#x201c;Kaiteki&#x201d; position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects. Eur Arch Oto-Rhino-Laryngol. 2016;273(4):939&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">26141752</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers AD, Amato I, Albers MW. Olanzapine improved symptoms and olfactory function in an olfactory reference syndrome patient. Physiol J Neuropsychiatry Clin Neurosci. 2018;30(2):164&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015176</ArticleId><ArticleId IdType="pubmed">29132274</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis BN, Croy I, Haehner A. Long lasting phantosmia treated with venlafaxine. Neurocase. 2012;18(2):112&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">21942993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Heilmann S, H&#xfc;ttenbriuk KB. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope. 2002;112(11):2076&#x2013;2080.</Citation><ArticleIdList><ArticleId IdType="pubmed">12439184</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelazim MH, Abdelazim AH, Ismaiel WF, et al.Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients. Eur Arch Oto-Rhino-Laryngol. 2022:0123456789. doi:10.1007/s00405-022-07424-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-022-07424-5</ArticleId><ArticleId IdType="pmc">PMC9107294</ArticleId><ArticleId IdType="pubmed">35567630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Landis BN, H&#xfc;ttenbrink K-B. Smell and taste disorders.
Accessed September 11, 2021. https://www.awmf.org/leitlinien/detail/ll/017-050.html</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341581</ArticleId><ArticleId IdType="pubmed">22558054</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama S, Ueha R, Kondo K. Loss of smell and taste in patients with suspected COVID-19: analyses of patients&#x2019; reports on social media. J Med Internet Res. 2021;23(4):e26459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064705</ArticleId><ArticleId IdType="pubmed">33788699</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat M, Rezaei N, Roozbeh M, et al.Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol. 2021;21(1). doi:10.1186/s12883-021-02152-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02152-5</ArticleId><ArticleId IdType="pmc">PMC7960879</ArticleId><ArticleId IdType="pubmed">33726699</ArticleId></ArticleIdList></Reference><Reference><Citation>Anonymous. The
Smell and Taste Association of North America. Published
2021. Accessed April 20, 2021. https://thestana.org/</Citation></Reference><Reference><Citation>Mainland JD, Barlow LA, Munger SD, et al.Identifying treatments for taste and smell disorders: gaps and opportunities. Chem Senses. 2020;45(7):493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7545248</ArticleId><ArticleId IdType="pubmed">32556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Boateng K. The Smell Podcast.
Published online 2021. https://www.thesmellpodcast.com/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>